Statement Of Financial Position [Abstract]

Pharming Group N.V. - Filing #5829944

Concept As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of financial position [abstract]
Assets [abstract]
Non-current assets [abstract]
Property, plant and equipment
7,752,000 USD
9,689,000 USD
Right-of-use assets
16,382,000 USD
23,777,000 USD
Intangible assets other than goodwill
61,039,000 USD
71,267,000 USD
Investments accounted for using equity method
466,000 USD
2,285,000 USD
Deferred tax assets
30,544,000 USD
29,761,000 USD
Non-current assets
121,545,000 USD
146,512,000 USD
Current assets [abstract]
Current inventories
55,724,000 USD
56,760,000 USD
Trade and other current receivables
54,823,000 USD
46,158,000 USD
Cash and cash equivalents
54,944,000 USD
61,741,000 USD
207,342,000 USD
Current assets
278,440,000 USD
316,342,000 USD
Assets
399,985,000 USD
462,854,000 USD
Equity and liabilities [abstract]
Equity [abstract]
Issued capital
7,769,000 USD
7,669,000 USD
Retained earnings
275,489,000 USD
265,262,000 USD
Share premium
488,990,000 USD
478,431,000 USD
Other reserves
209,000 USD
2,057,000 USD
Equity
275,489,000 USD
488,990,000 USD
209,000 USD
221,061,000 USD
7,769,000 USD
478,431,000 USD
7,669,000 USD
265,262,000 USD
218,781,000 USD
2,057,000 USD
204,638,000 USD
462,297,000 USD
7,509,000 USD
256,431,000 USD
8,737,000 USD
Liabilities [abstract]
Non-current liabilities [abstract]
Non-current liabilities
105,122,000 USD
166,105,000 USD
Current liabilities [abstract]
Trade and other current payables
66,611,000 USD
72,528,000 USD
Current liabilities
73,802,000 USD
77,968,000 USD
Equity and liabilities
399,985,000 USD
462,854,000 USD

Talk to a Data Expert

Have a question? We'll get back to you promptly.